Due to strong marketing and promotion efforts by drug makers, there are now more than a billion people taking statins. Women between the ages of 40 and 80 have been aggressively targeted by certain drug makers in advertisements suggesting that statins—the so-called cholesterol lowering drugs—protect against cardiovascular disease. The largest selling drug in this category—by far-- is Lipitor.
As a result, millions of women who do not have cardiovascular disease have been prescribed this drug. There is a steadily growing amount of medical evidence showing that these women get no benefit from taking drugs such as Lipitor—but they do get risks. Specifically, statins such as Lipitor carry a risk of developing type II diabetes, myopathy, and other complications. Many doctors have suggested that it is safer, cheaper, and far less risky to simply take a baby aspirin each day.
The subject of risks versus questionable benefits was recently written about in the Journal of the American Medical Association (JAMA) by Dr. John Ioannidis, director of the Stanford Prevention Research Center at Stanford University School of Medicine. The author, noting that Lipitor sales alone between 1996 and 2011 exceeded 120 billion, urged that some of these profits be used to fund clinical trials to see if Lipitor and drugs like it are providing any true benefit in light of the risks they pose.
Learn More About The Lipitor Diabetes Lawsuit, Lipitor Side Effects & The Relationship Between Type 2 Diabetes And Lipitor In Women.